Adalat LA 60mg Tablets incorrectly packaged in 30mg carton (CLDA (16)A/08)

Quadrant Pharmaceuticals Limited (repackaged by Pharmagen Limited) are asking pharmacists to check stocks of Adalat LA 30mg as there is a possibility that some packs of Parallel Imported LA 60mg may have been incorrectly repackaged.

Product information

CLDA number

CLDA (16)A/08

MDR number

MDR 103-09/16

Company name

Product Licence Holder: Quadrant Pharmaceuticals Limited

Repackaged by: Pharmagen Limited

Product description

Adalat LA 60mg Tablets incorrectly packaged in 30mg carton

PL 20774/1320

Batch number/expiry

Originator Batch No. Parallel Import Batch No. Expiry date
BXH84X5 IB: C1604 08/2019

Brief description of the problem

There is a possibility that some packs of Parallel Imported Adalat LA 60mg Tablets batch BXH84X5 (originator name Adalat Oros 60mg) have been incorrectly repackaged into 30mg cartons.

Pharmacists are asked to check their stock of Adalat LA 30mg Tablets for any packs of batch BXH84X5.

Company contact

If a 30mg carton is found, please contact:

AAH Customer Services
Tel: 0844 561 8899

Help us improve GOV.UK

Don’t include personal or financial information like your National Insurance number or credit card details.